({{currency.regularMarketChangePercent.toFixed(2)}}%)
  • What We Do
    • Corporate Strategy
    • Market Evaluation
    • Inorganic Growth
    • Innovation
    • Leadership Search
    • Professional Training & Development
    • Industries Served
  • BroadBranch Perspectives
  • About Us
    • Mission, Vision and Values
    • Ethics
    • Our Team
    • History
    • Diversity, Equity, and Inclusion at BroadBranch Advisors
  • Ethics
  • Work@BroadBranch
    • Our Culture
    • Current Openings
  • Contact Us
Site Logo

Paul Peddrick

  • Meal Kits are Here to Stay
    March 31, 2022
  • Statement on the Russian-Ukrainian Conflict
    March 18, 2022
  • Broadbranch Business Bookshelf Collection 1
    Broadbranch Business Bookshelf Collection 1
    June 16, 2020
  • What Now?
    May 21, 2020
  • 中国新常态
    April 23, 2020
  • China's New Normal
    China’s New Normal
    April 23, 2020
  • Seven strategic concepts to sharpen your COVID-19 response
    March 23, 2020
  • 1
  • 2
  • 3
Recent Posts
  • US Healthcare Trends Impacting Molecular Diagnostics (Q2 2025) August 15, 2025
  • Enter the Antibody Drug Conjugates (ADC) Renaissance June 10, 2025
  • Recent Successful Use Cases of Gen AI in Drug Discovery May 1, 2025
  • SLAS 2025: Pioneering the Future of Laboratory Automation March 13, 2025
  • Sustainability in bioprocessing December 10, 2024

Let’s Begin A Conversation

In about 15 minutes we can determine if our approach can provide value to your organization.

Contact Us
SERVICES
  • Corporate Strategy
  • Market Evaluation
  • Inorganic Growth
  • Innovation
  • Leadership Search
  • Professional Training & Development
BroadBranch Advisors

For over 20 years, BroadBranch has partnered with its clients across a broad spectrum of industries to solve complex business challenges. Using solid analytics, logical arguments, and fresh market perspectives, we deliver clear and actionable recommendations that drive growth and performance.

Corporate

  • Corporate Strategy
  • Market Evaluation
  • Inorganic Growth
  • Innovation
  • Leadership Search
  • Professional Training & Development

Perspectives

  • US Healthcare Trends Impacting Molecular Diagnostics (Q2 2025) August 15, 2025
  • Enter the Antibody Drug Conjugates (ADC) Renaissance June 10, 2025
  • Recent Successful Use Cases of Gen AI in Drug Discovery May 1, 2025

Fresh perspectives, delivered.

Sign up for the BroadBranch Newsletter

Select list(s) to subscribe to

© 2025 BroadBranch Advisors. All rights reserved

We use cookies to ensure that we give you the best experience on our website. You can view our Cookie Policy here if you'd like.Ok